A Comparative Study Examining the Management of Bowen’s Disease in the United Kingdom and Australia

Background and Aim. The optimum management of Bowen’s Disease (BD) is undefined. A review of current practice is required to allow the development of best practice guidelines. Methods. All BD cases, diagnosed in one UK centre and one Australian centre over a year (1 July 2012–30 June 2013), were ana...

Full description

Saved in:
Bibliographic Details
Main Authors: G. L. Morley, J. H. Matthews, I. Verpetinske, G. A. Thom
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Dermatology Research and Practice
Online Access:http://dx.doi.org/10.1155/2015/421460
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849407735814160384
author G. L. Morley
J. H. Matthews
I. Verpetinske
G. A. Thom
author_facet G. L. Morley
J. H. Matthews
I. Verpetinske
G. A. Thom
author_sort G. L. Morley
collection DOAJ
description Background and Aim. The optimum management of Bowen’s Disease (BD) is undefined. A review of current practice is required to allow the development of best practice guidelines. Methods. All BD cases, diagnosed in one UK centre and one Australian centre over a year (1 July 2012–30 June 2013), were analysed retrospectively. Patients with BD were identified from histopathology reports and their medical records were analysed to collect demographic data, site of lesion, and treatment used. Results. The treatment of 155 lesions from the UK centre and 151 lesions from the Australian centre was analysed. At both centres BD was most frequently observed on the face: UK had 70 (45%) lesions and Australia had 83 (55%) lesions (P=0.08). The greatest number of lesions was managed by the plastic surgery department in the UK centre, 72 (46%), and the dermatology department in the Australian centre, 121 (80%). The most common therapy was surgical excision at both centres. Conclusions. In both UK and Australia, BD arises on sun-exposed sites and was most commonly treated with surgical excision despite a lack of robust evidence-based guidelines.
format Article
id doaj-art-47a9718e31b94d9d95f59eb66df903fb
institution Kabale University
issn 1687-6105
1687-6113
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Dermatology Research and Practice
spelling doaj-art-47a9718e31b94d9d95f59eb66df903fb2025-08-20T03:35:58ZengWileyDermatology Research and Practice1687-61051687-61132015-01-01201510.1155/2015/421460421460A Comparative Study Examining the Management of Bowen’s Disease in the United Kingdom and AustraliaG. L. Morley0J. H. Matthews1I. Verpetinske2G. A. Thom3College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UKCollege of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UKRussells Hall Hospital, Pensnett Road, Dudley, West Midlands DY1 2HQ, UKRoyal Perth Hospital, 197 Wellington Street, Perth, WA 6000, AustraliaBackground and Aim. The optimum management of Bowen’s Disease (BD) is undefined. A review of current practice is required to allow the development of best practice guidelines. Methods. All BD cases, diagnosed in one UK centre and one Australian centre over a year (1 July 2012–30 June 2013), were analysed retrospectively. Patients with BD were identified from histopathology reports and their medical records were analysed to collect demographic data, site of lesion, and treatment used. Results. The treatment of 155 lesions from the UK centre and 151 lesions from the Australian centre was analysed. At both centres BD was most frequently observed on the face: UK had 70 (45%) lesions and Australia had 83 (55%) lesions (P=0.08). The greatest number of lesions was managed by the plastic surgery department in the UK centre, 72 (46%), and the dermatology department in the Australian centre, 121 (80%). The most common therapy was surgical excision at both centres. Conclusions. In both UK and Australia, BD arises on sun-exposed sites and was most commonly treated with surgical excision despite a lack of robust evidence-based guidelines.http://dx.doi.org/10.1155/2015/421460
spellingShingle G. L. Morley
J. H. Matthews
I. Verpetinske
G. A. Thom
A Comparative Study Examining the Management of Bowen’s Disease in the United Kingdom and Australia
Dermatology Research and Practice
title A Comparative Study Examining the Management of Bowen’s Disease in the United Kingdom and Australia
title_full A Comparative Study Examining the Management of Bowen’s Disease in the United Kingdom and Australia
title_fullStr A Comparative Study Examining the Management of Bowen’s Disease in the United Kingdom and Australia
title_full_unstemmed A Comparative Study Examining the Management of Bowen’s Disease in the United Kingdom and Australia
title_short A Comparative Study Examining the Management of Bowen’s Disease in the United Kingdom and Australia
title_sort comparative study examining the management of bowen s disease in the united kingdom and australia
url http://dx.doi.org/10.1155/2015/421460
work_keys_str_mv AT glmorley acomparativestudyexaminingthemanagementofbowensdiseaseintheunitedkingdomandaustralia
AT jhmatthews acomparativestudyexaminingthemanagementofbowensdiseaseintheunitedkingdomandaustralia
AT iverpetinske acomparativestudyexaminingthemanagementofbowensdiseaseintheunitedkingdomandaustralia
AT gathom acomparativestudyexaminingthemanagementofbowensdiseaseintheunitedkingdomandaustralia
AT glmorley comparativestudyexaminingthemanagementofbowensdiseaseintheunitedkingdomandaustralia
AT jhmatthews comparativestudyexaminingthemanagementofbowensdiseaseintheunitedkingdomandaustralia
AT iverpetinske comparativestudyexaminingthemanagementofbowensdiseaseintheunitedkingdomandaustralia
AT gathom comparativestudyexaminingthemanagementofbowensdiseaseintheunitedkingdomandaustralia